375 related articles for article (PubMed ID: 28471269)
1. Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.
Augusto JF; Poli C; Beauvillain C; Subra JF; Jaillon S; Renier G; Chevailler A; Puéchal X; Delneste Y; Jeannin P
Int Rev Immunol; 2017 May; 36(3):145-153. PubMed ID: 28471269
[TBL] [Abstract][Full Text] [Related]
2. Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
Brilland B; Vinatier E; Subra JF; Jeannin P; Augusto JF; Delneste Y
Front Immunol; 2020; 11():626343. PubMed ID: 33664737
[TBL] [Abstract][Full Text] [Related]
3. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.
Mantovani A; Valentino S; Gentile S; Inforzato A; Bottazzi B; Garlanda C
Ann N Y Acad Sci; 2013 May; 1285():1-14. PubMed ID: 23527487
[TBL] [Abstract][Full Text] [Related]
4. Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.
Kravitz MS; Pitashny M; Shoenfeld Y
J Clin Immunol; 2005 Nov; 25(6):582-91. PubMed ID: 16380821
[TBL] [Abstract][Full Text] [Related]
5. Pattern recognition by pentraxins.
Agrawal A; Singh PP; Bottazzi B; Garlanda C; Mantovani A
Adv Exp Med Biol; 2009; 653():98-116. PubMed ID: 19799114
[TBL] [Abstract][Full Text] [Related]
6. Pentraxins, anti-pentraxin antibodies, and atherosclerosis.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Cozzi F; Doria A
Clin Rev Allergy Immunol; 2009 Aug; 37(1):36-43. PubMed ID: 19016000
[TBL] [Abstract][Full Text] [Related]
7. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility.
Garlanda C; Bottazzi B; Bastone A; Mantovani A
Annu Rev Immunol; 2005; 23():337-66. PubMed ID: 15771574
[TBL] [Abstract][Full Text] [Related]
8. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
9. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
Mantovani A; Garlanda C; Doni A; Bottazzi B
J Clin Immunol; 2008 Jan; 28(1):1-13. PubMed ID: 17828584
[TBL] [Abstract][Full Text] [Related]
10. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.
Bottazzi B; Vouret-Craviari V; Bastone A; De Gioia L; Matteucci C; Peri G; Spreafico F; Pausa M; D'Ettorre C; Gianazza E; Tagliabue A; Salmona M; Tedesco F; Introna M; Mantovani A
J Biol Chem; 1997 Dec; 272(52):32817-23. PubMed ID: 9407058
[TBL] [Abstract][Full Text] [Related]
11. The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer.
Doni A; Stravalaci M; Inforzato A; Magrini E; Mantovani A; Garlanda C; Bottazzi B
Front Immunol; 2019; 10():712. PubMed ID: 31019517
[TBL] [Abstract][Full Text] [Related]
12. The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling.
Inforzato A; Jaillon S; Moalli F; Barbati E; Bonavita E; Bottazzi B; Mantovani A; Garlanda C
Tissue Antigens; 2011 Apr; 77(4):271-82. PubMed ID: 21388349
[TBL] [Abstract][Full Text] [Related]
13. The yin-yang of long pentraxin PTX3 in inflammation and immunity.
Daigo K; Mantovani A; Bottazzi B
Immunol Lett; 2014 Sep; 161(1):38-43. PubMed ID: 24792672
[TBL] [Abstract][Full Text] [Related]
14. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications.
Cieślik P; Hrycek A
Autoimmunity; 2012 Mar; 45(2):119-28. PubMed ID: 21988562
[TBL] [Abstract][Full Text] [Related]
15. Pentraxins in innate immunity: lessons from PTX3.
Deban L; Jaillon S; Garlanda C; Bottazzi B; Mantovani A
Cell Tissue Res; 2011 Jan; 343(1):237-49. PubMed ID: 20683616
[TBL] [Abstract][Full Text] [Related]
16. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.
Garlanda C; Hirsch E; Bozza S; Salustri A; De Acetis M; Nota R; Maccagno A; Riva F; Bottazzi B; Peri G; Doni A; Vago L; Botto M; De Santis R; Carminati P; Siracusa G; Altruda F; Vecchi A; Romani L; Mantovani A
Nature; 2002 Nov; 420(6912):182-6. PubMed ID: 12432394
[TBL] [Abstract][Full Text] [Related]
17. Pentraxins and atherosclerosis: the role of PTX3.
Garlanda C; Bottazzi B; Moalli F; Deban L; Molla F; Latini R; Mantovani A
Curr Pharm Des; 2011; 17(1):38-46. PubMed ID: 21226667
[TBL] [Abstract][Full Text] [Related]
18. PTX3 as a paradigm for the interaction of pentraxins with the complement system.
Inforzato A; Doni A; Barajon I; Leone R; Garlanda C; Bottazzi B; Mantovani A
Semin Immunol; 2013 Feb; 25(1):79-85. PubMed ID: 23747040
[TBL] [Abstract][Full Text] [Related]
19. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases.
Jaillon S; Bonavita E; Gentile S; Rubino M; Laface I; Garlanda C; Mantovani A
Int Arch Allergy Immunol; 2014; 165(3):165-78. PubMed ID: 25531094
[TBL] [Abstract][Full Text] [Related]
20. Pentraxins in humoral innate immunity.
Inforzato A; Bottazzi B; Garlanda C; Valentino S; Mantovani A
Adv Exp Med Biol; 2012; 946():1-20. PubMed ID: 21948359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
